← Leaderboards
Blase Christopher Billack
St. John'S University
$915,339
Attributed
$915,339
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $218.3K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$915,339 · 2
By mechanism
R16$546,339 · 1
SC2$369,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Dermis”
- Yulia Sapir Lekhovitser · Fesariustherapeutics, Inc.$5,341,586
- Yosuke Kumamoto · Rbhs-New Jersey Medical School$3,366,190
- Ibrahim Ozbolat · Pennsylvania State University, The$2,786,229
- Stephanie Deshayes · Tempo Therapeutics, Inc.$2,549,496
- Adrian Buganza Tepole · Purdue University$2,545,560
- Kang I Ko · University Of Pennsylvania$2,216,175
Research focus
DermisEdemaCutaneousDermalCicatrixEbselenChemotherapyComplexAffectChemical Warfare AgentsApoptosis3-DimensionalChemotherapy-Oncologic ProcedureDoseAdverse EffectsAchievementAntidotesBullaCasp3 GeneCasp9 GeneCell Culture TechniquesAntineoplastic AgentsCellsElectrolytes
Grant awards (7)
Dermal-Epidermal Junction Disruptors: Toxicodynamic Mechanisms$164,000
R16 · FY2025 · GM · contact PI
Dermal-Epidermal Junction Disruptors: Toxicodynamic Mechanisms$164,000
R16 · FY2024 · GM · contact PI
Dermal-Epidermal Junction Disruptors: Toxicodynamic Mechanisms$54,339
R16 · FY2024 · GM · contact PI
Dermal-Epidermal Junction Disruptors: Toxicodynamic Mechanisms$164,000
R16 · FY2023 · GM · contact PI
Dermal-Epidermal Junction Disruptors: Mechanistic Insights$123,000
SC2 · FY2022 · GM · contact PI
Dermal-Epidermal Junction Disruptors: Mechanistic Insights$123,000
SC2 · FY2021 · GM · contact PI
Dermal-Epidermal Junction Disruptors: Mechanistic Insights$123,000
SC2 · FY2020 · GM · contact PI